Compounds > gabexate
Page last updated: 2024-10-27

gabexate and Dextro-Looped Transposition of the Great Arteries

gabexate has been researched along with Dextro-Looped Transposition of the Great Arteries in 1 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chihara, K1
Akiyama, F1
Shinozaki, T1
Shimamoto, M1
Takahashi, K1
Imura, H1
Yamazaki, F1
Kawarazaki, S1

Other Studies

1 other study available for gabexate and Dextro-Looped Transposition of the Great Arteries

ArticleYear
[Disseminated intravascular coagulation (DIC) following open heart surgery and great vessel surgery. The result of early administration of gabexate mesilate (FOY)].
    Kyobu geka. The Japanese journal of thoracic surgery, 1984, Volume: 37, Issue:8

    Topics: Adolescent; Adult; Aged; Blood Transfusion; Cardiac Surgical Procedures; Coronary Disease; Dissemina

1984